1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow REGN20934: new trials by email Literature Review of REGN20934 trials Research Report on REGN20934
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity REGN20934, Placebo - Overweight or Obesity | Phase 1 | Recruiting | Regeneron Pharmaceuticals | 90 | 2026-06-29 | 2026-09-25 |
Obesity (1) · Overweight (1)
United States (1)